Loading dashboard...
Peptide Assistant
Online
AI can make mistakes. Verify important medical data.
Press Enter to send
G
Medical Engine
Guest Account
AI can make mistakes. Verify important medical data.
Press Enter to send
Medical Engine
Guest Account
Loading dashboard...
FDA-approved for HSDD. Works on desire (brain), not just mechanics (blood).
PT-141 (Bremelanotide) activates the Hypothalamus via MC3R and MC4R melanocortin receptors. Unlike PDE5 inhibitors (Viagra/Cialis) which address vascular mechanics, PT-141 creates the biological state of arousal centrally.
The pathway from injection to biological drive
Crosses Blood-Brain Barrier
MC3R / MC4R Saturation
Systemic Desire Lock
"30-40% of users experience nausea. Administer with 500mg ginger root or 4-8mg Zofran 30 mins prior to significantly improve the experience profile."
Initiate CNS desire and central arousal pathways.
Enable vascular support and sustained blood flow dynamics.
By combining a Central Melanocortin Agonist with a Peripheral PDE5 Inhibitor, researchers address both the psychic and physical dimensions of function simultaneously.